Related News
-
Celator Pharmaceuticals…
Friday, September 3, 2010
Princeton, NJ -- Celator Pharmaceuticals, a privately held pharmaceutical company developing new and more effective… more...
-
Saved by Your Blood
Tuesday, August 31, 2010
A courageous teenager battling a life-threatening condition has been hailed an inspiration after enduring dozens of… more...
-
For Treatment of Non-Hodgkin'…
Tuesday, August 31, 2010
BURLINGTON, Mass. -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and… more...
-
Brazil: Cancer Patients to Be…
Monday, August 30, 2010
Under a massive expansion of its oncology services, Brazil’s national health care system (SUS) will offer cancer… more...
-
LFB's Recombinant Anti-CD20…
Thursday, August 26, 2010
LES ULIS, France -- The recombinant anti-CD20 monoclonal antibody produced by LFB Biotechnologies received orphan drug… more...
News
-
CheckOrphan NewsFlash April 30,…
4/30/2010
CheckOrphan NewsFlash for Tuesday, March 30, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
-
CheckOrphan NewsFlash April 9,…
4/09/2010
CheckOrphan NewsFlash for Friday, April 9, 2010: breaking news about rare diseases, orphan diseases, orphan drugs, and…
-
CheckOrphan NewsFlash April 1,…
4/01/2010
CheckOrphan NewsFlash for Thursday, April 1, 2010: breaking news about rare diseases, orphan diseases, orphan drugs,…
NewsFlash
More News
-
Results From Investigator-Sponsored…
NOVATO, Calif. -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that… more...
-
Celldex Therapeutics Regains Worldwide…
NEEDHAM, Mass. -- Celldex Therapeutics, Inc. (Nasdaq: CLDX) announced today it will… more...
-
Merck Serono's Cladribine Tablets for…
GENEVA, Switzerland -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany,… more...
-
Santhera and Ipsen Enter Into Licensing…
Liestal, Switzerland and Paris, France -- Santhera Pharmaceuticals (SIX: SANN) and Ipsen… more...
-
Celator Pharmaceuticals Raises $20…
Princeton, NJ -- Celator Pharmaceuticals, a privately held pharmaceutical company… more...
Treatment News
His Holiness Karekin II Joins ABMDR as Potential Donor
| More
Friday, July 30, 2010
LOS ANGELES -- His Holiness Karekin II, Supreme Patriarch and Catholicos of All Armenians, became the latest potential stem cell donor to join the ranks of the Armenian Bone Marrow Donor Registry (ABMDR).
The pontiff’s membership in the registry was formalized on July 22, following a simple, non-intrusive medical test that took place at the Catholicosal residence in Etchmiadzin, Armenia. The brief standard test, which ABMDR volunteers administer to all potential stem cell donors before they can join the registry, confirmed that the Catholicos is in excellent health and hence qualified to donate bone marrow stem cells, should he be identified as a match for a patient needing bone marrow transplantation.
Commenting on his decision to join the ABMDR, the Catholicos stated, “This is an important day filled with blessings. I am pleased to note that by becoming a potential donor one can help save someone’s life. To this end, I encourage the citizens of Armenia as well as Armenians throughout the diaspora to actively participate in the work of the registry, with the understanding that it might be one of us who can give the gift of life by donating a little blood.”
The Catholicos continued: “With this I would like to express my gratitude and appreciation to all those who are supporting the Armenian Bone Marrow Donor Registry, and once again encourage each and everyone to be of assistance by registering as potential stem cell donors.”
An ABMDR representative in Yerevan said that the Catholicos volunteered to join the registry as a personal gesture of support and, more importantly, to help raise public awareness of the critical need for Armenians worldwide to register with the ABMDR as potential stem cell donors. The same source added that since ethnic Armenians have a unique genetic makeup, often their only chance of surviving a life-threatening blood-related illness is to receive a bone marrow transplant from an Armenian donor.
Last month, for the first time in the history of Armenia and the Caucasus region, the ABMDR performed a stem cell harvesting procedure in Yerevan. Thanks to the procedure, during which stem cells were harvested from a healthy donor, a bone marrow transplant was performed in Belgium, saving the life of a patient who suffered from a potentially terminal blood-related disease.
As 2010 marks the 10th anniversary of the ABMDR, a series of special events—including a gala fundraiser on July 25 at the Glendale Hilton in Glendale—has been planned for throughout the year. In addition to recruiting bone marrow donors, these events will seek support for the establishment of a stem cell transplantation center in Armenia and the creation of support groups throughout the world.
Established in 1999, the ABMDR, a nonprofit organization, helps Armenians worldwide survive life-threatening blood-related illnesses by recruiting and matching donors to those requiring bone marrow stem cell transplants. To date, the registry has recruited over 15,000 donors across three continents, identified 1,696 patients, found 1,419 potential matches, and facilitated 10 bone marrow transplants.
For more information, call (323) 663-3609 or visit http://www.abmdr.am.
© 2010 Armenian Weekly
Source: The Armenian Weekly
Log in to comment.